By Kenneth Lim
Boston, March 24 - King Pharmaceuticals Inc. priced its $400 million offer of 20-year convertible senior notes on Friday at the cheap end of talk with a coupon of 1.25% and an initial conversion premium of 20%.
The notes, which mature on April 1, 2026, were talked at a coupon between 0.75% and 1.25% with an initial conversion premium between 20% and 25%, market sources confirmed.
Citigroup, UBS Investment Group and Banc of America Securities were the bookrunners of the Rule 144A deal. They have a greenshoe option to purchase a further $60 million of notes.
The convertibles were offered at par, and may be converted into King Pharmaceuticals shares at an initial conversion price of $20.83, or a conversion ratio of 48.0031 shares for every note.
The convertibles are non-callable for the first seven years, and have puts in years seven, 10 and 15.
There is a contingent conversion trigger at 110% and contingent payment at 120%.
The securities have dividend protection and takeover protection in the form of a premium make-whole feature and a change-of-control put.
The convertibles also have a net-share settlement feature.
The Bristol, Tenn.-based pharmaceutical company has earmarked the proceeds of the deal to redeem or repurchase its existing 2.75% convertibles due 2021, of which $345 million remain outstanding. It will also use the proceeds for general corporate purposes.
Issuer: | King Pharmaceuticals Inc.
|
Issue: | Convertible senior notes
|
Bookrunner: | Citigroup, UBS Investment Group and Banc of America Securities
|
Amount: | $400 million
|
Greenshoe: | $60 million
|
Maturity: | April 1, 2026
|
Coupon: | 1.25%
|
Price: | Par
|
Yield: | 1.25%
|
Conversion premium: | 20%
|
Conversion price: | $20.83
|
Conversion ratio: | 48.0031
|
Contingent conversion: | 110%
|
Contingent payment: | 120%
|
Net-share settlement: | Yes
|
Dividend protection: | Yes
|
Takeover protection: | Change of control put with premium make whole
|
Hard-call protection: | Non-callable 7 years
|
Puts: | Years 7, 10, 15
|
Price talk: | 0.75%-1.25%, up 20%-25%
|
Pricing date: | March 24
|
Settlement date: | March 29
|
Distribution: | Rule 144A
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.